These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9324027)

  • 1. Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy.
    Cooley HM; Snowden JA; Grigg AP; Wicks IP
    Arthritis Rheum; 1997 Sep; 40(9):1712-5. PubMed ID: 9324027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation.
    Snowden JA; Kearney P; Kearney A; Cooley HM; Grigg A; Jacobs P; Bergman J; Brooks PM; Biggs JC
    Arthritis Rheum; 1998 Mar; 41(3):453-9. PubMed ID: 9506573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia].
    Zhang YZ; Zhang BL; Yao SQ; Liu HC; Lou FD; Gao CJ; Han XP; Wu XX; Zhao Y; Wang QS; Jing Y; Zhang M; Jin HJ; Shi ZJ; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):81-5. PubMed ID: 12667296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation in acute leukemia.
    Gorin NC
    J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation.
    Kaffenberger BH; Wong HK; Jarjour W; Andritsos LA
    J Am Acad Dermatol; 2013 Mar; 68(3):489-92. PubMed ID: 22981608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma.
    Isshiki I; Okamoto S; Kakimoto T; Chen CK; Mori T; Yokoyama K; Hattori Y; Ikeda Y
    Int J Hematol; 2006 Nov; 84(4):354-8. PubMed ID: 17118763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous hematopoietic stem cell transplantation in autoimmune diseases.
    Annaloro C; Onida F; Lambertenghi Deliliers G
    Expert Rev Hematol; 2009 Dec; 2(6):699-715. PubMed ID: 21082959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
    Bingham SJ; Snowden J; McGonagle D; Richards S; Isaacs J; Morgan G; Emery P
    J Rheumatol Suppl; 2001 Oct; 64():21-4. PubMed ID: 11642498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support.
    Johnsen HE; Björkstrand B; Carlson K; Gruber A; Blystad A; Fast A; Boesen AM; Björkholm M; Sallerfors B; Ruutu T; Carneskog J; Malm A; Geisler C; Lehtinen M; Schrøder H; Brinch L; Remes K; Tidefelt U; Heilmann C; Hörnsten P; Thorling K; Daugaard G
    Leuk Lymphoma; 1996 Dec; 24(1-2):81-91. PubMed ID: 9049964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [10 years transplantation of bone marrow and hematopoietic stem cells in adults at the Hannover Medical School].
    Link H; Diedrich H; Arseniev L; Stoll M; Ebell W; Freund M; Tischler J; Casper J; Hübner G; Schöffski P; Diehl S; Goes A; Jacobs R; Kadar J; Stangel W; Müller R; Rittmann KL; Wildfang I; Bucsky P; Bettoni C; Schmidt RE; Riehm H; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():3-17. PubMed ID: 8692116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interleukin-2 treatment before and after autologous stem cell transplantation in hematologic malignancies: clinical and immunologic effects.
    De Laurenzi A; Iudicone P; Zoli V; De Rosa L; Guglielmetti M; Pescarollo A; Papetti C; Pacilli L; Lapponi P; Petti N
    J Hematother; 1995 Apr; 4(2):113-20. PubMed ID: 7633841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
    Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders.
    Keilholz U; Körbling M; Fehrentz D; Bauer H; Hunstein W
    Cancer; 1989 Aug; 64(3):641-5. PubMed ID: 2568164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro chemoseparation as part of autologous bone marrow transplantation (ABMT) in hematologic malignancy.
    Körbling M; Hunstein W
    Blut; 1984 Apr; 48(4):189-99. PubMed ID: 6370338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.